Pharmaceutical industry invested £381m into UK R&D collaborations

Pharmaceutical industry invested £381m into UK R&D collaborations

According to newly published data, the pharmaceutical industry invested more than £381m on R&D activities in the UK during 2019 – an increase from just over £377m in 2018.

The data was published by Disclosure UK, a public pharmaceutical industry-led database which details aggregate R&D spend, as well as individual payments and benefits in kind made to UK healthcare professionals (HCPs) and healthcare organisations (HCOs), in order to increase transparency across the sector.

As previously announced by ABPI, the 2019 data has been published in a way designed to minimise any pressure on individual NHS workers, hospitals or other NHS organisations as they respond to the ongoing coronavirus outbreak. This has meant some of the 2019 data is not broken down by individual HCPs and HCOs, as it usually would have been done.

This change is intended to be temporary and ABPI plan to republish the usual, more detailed data as soon as possible.

The available 2019 figures show:

  • £538.2million has been disclosed by pharmaceutical companies for 2019, compared with £503million in 2018 (excluding joint-working*).
  • £381.2million of this was spent on R&D, compared with £377.3million in 2018.
  • £157million of this was spent on non-R&D collaborations with HCPs and HCOs in 2019, vs £125.7million in 2018 (excluding joint-working*) Much of this increase was due to payments to healthcare organisations.

A total of 11 new companies have disclosed payments this year, bringing the total number of companies using Disclosure UK to 143.

Richard Torbett, Chief Executive of the ABPI, said: “The 2019 disclosure data available so far tells a hugely positive story – the third successive year of increasing investment by industry in UK R&D.  This can only be a good thing for patients and the NHS.

“We will publish the normal breakdown of disclosure data as soon as we are able, and when we do, it should also help us understand more about how the data has changed over time. 

“We’re proud of the work we do with the NHS, without which the development of new medicines and vaccines would be impossible, and will continue strive for the highest levels of openness and transparency in the relationships between industry and healthcare professionals.”

NHE July/August 21

NHE July/August 21

Prioritising staff wellbeing

NHE’s July/August 2021 edition focuses on some of the key, defining aspects of a successful, supported health service: Mental Health & Workforce. Elsewhere, we take on the incredibly topical Infection Prevention and address the role which Pharma will play in both our NHS and wider health environment.

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Net-Zero NHS

As was outlined by Sir Simon Stevens when the NHS announced their green plans back in 2020, 5,700 lives could be saved each year by improved air quality. Even more could see their overall health improve and be in a position to self-manage their conditions, rather than requiring NHS treatment. Covid-19 has already left the NHS with a sizeable treatment backlog, so anything which can be done to improve patient health and reduce demand is beneficial for all.

Working together, we can help the NHS realise its green ambitions as per the Net-Zero National Health Service report and its ambitious 2040 target. Join us on August 25, 2021 for our Net-Zero NHS event, where we will be joined by health sector leaders and innovators for a day of sharing best practice and networking.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all